Abbrea Capital, LLC Amgen Inc Transaction History
Abbrea Capital, LLC
- $755 Million
- Q2 2024
A detailed history of Abbrea Capital, LLC transactions in Amgen Inc stock. As of the latest transaction made, Abbrea Capital, LLC holds 8,849 shares of AMGN stock, worth $2.29 Million. This represents 0.37% of its overall portfolio holdings.
Number of Shares
8,849
Previous 8,900
0.57%
Holding current value
$2.29 Million
Previous $2.53 Million
9.29%
% of portfolio
0.37%
Previous 0.33%
Shares
27 transactions
Others Institutions Holding AMGN
# of Institutions
3,125Shares Held
409MCall Options Held
7.56MPut Options Held
7.2M-
Vanguard Group Inc Valley Forge, PA52.4MShares$13.6 Billion0.31% of portfolio
-
Black Rock Inc. New York, NY46MShares$11.9 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.3MShares$7.6 Billion0.39% of portfolio
-
Morgan Stanley New York, NY14.7MShares$3.81 Billion0.35% of portfolio
-
Primecap Management CO Pasadena, CA14.3MShares$3.7 Billion3.44% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $139B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...